Tributary Capital Management’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-3,900
Closed -$250K 256
2018
Q4
$250K Hold
3,900
0.02% 200
2018
Q3
$349K Hold
3,900
0.03% 199
2018
Q2
$310K Sell
3,900
-100
-3% -$8.3K 0.02% 200
2018
Q1
$357K Sell
4,000
-600
-13% -$57.6K 0.03% 188
2017
Q4
$480K Sell
4,600
-200
-4% -$22.6K 0.04% 185
2017
Q3
$700K Sell
4,800
-100
-2% -$13.6K 0.06% 160
2017
Q2
$636K Sell
4,900
-100
-2% -$12.3K 0.06% 175
2017
Q1
$622K Sell
5,000
-400
-7% -$47.9K 0.06% 174
2016
Q4
$625K Sell
5,400
-700
-11% -$78K 0.07% 172
2016
Q3
$638K Hold
6,100
0.08% 174
2016
Q2
$602K Sell
6,100
-700
-10% -$72.4K 0.09% 173
2016
Q1
$681K Sell
6,800
-1,200
-15% -$124K 0.11% 168
2015
Q4
$958K Sell
8,000
-700
-8% -$81K 0.16% 152
2015
Q3
$941K Hold
8,700
0.16% 151
2015
Q2
$1.01M Hold
8,700
0.16% 151
2015
Q1
$1M Hold
8,700
0.16% 151
2014
Q4
$973K Hold
8,700
0.17% 147
2014
Q3
$825K Hold
8,700
0.17% 148
2014
Q2
$747K Hold
8,700
0.15% 143
2014
Q1
$607K Sell
8,700
-20,000
-70% -$1.58M 0.13% 144
2013
Q4
$2.42M Sell
28,700
-8,000
-22% -$633K 0.48% 112
2013
Q3
$2.83M Hold
36,700
0.58% 79
2013
Q2
$2.15M Buy
+36,700
New +$2.21M 0.35% 142

Other funds holding CELG

Tributary Capital Management's CELG Position: Q1 2019 in Review

Tributary Capital Management sold out of Celgene Corp (CELG) in Q1 2019, closing a stake of 3,900 shares — an estimated $250K sold.

Tributary Capital Management first reported a position in CELG in Q2 2013 and held it in 23 quarters. The position peaked at $2.83M in Q3 2013. 1,389 funds tracked by Wall St. Rank hold CELG as of Q1 2019.

  • Tributary Capital Management reported no remaining Celgene Corp position as of Q1 2019 after selling out during the quarter.
  • Tributary Capital Management sold 3,900 Celgene Corp shares in Q1 2019, an estimated $250K.
  • Tributary Capital Management first reported a position in Celgene Corp in Q2 2013 and held it in 23 quarters.
  • Tributary Capital Management's Celgene Corp position peaked at $2.83M in Q3 2013.
  • 1,389 funds tracked by Wall St. Rank held Celgene Corp as of Q1 2019.

Based on Tributary Capital Management's 13F filing for Q1 2019, filed 17 Apr 2019.